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Abstract: β,β-carotene-9’,10’-oxygenase2 (BCO2) is a carotenoid cleavage enzyme 
localized to the inner membrane of mitochondria. Hypothalamus is the key brain region 
that regulates energy homeostasis through nutrient sensing and signal integration from 
central and peripheral pathways. The aim of this study is to explore the impact of BCO2 
on maintaining mitochondrial function and hypothalamic metabolism, as well as the 
mechanism of why BCO2 -/- mice exhibit orexigenic phenotype. Using 129S6 wild type 
(WT) and BCO2 -/- mice model, we measured metabolic profiling differences in 
hypothalamus caused by the deletion of the BCO2 gene. Mitochondrial proteomic and 
functional analyses were also conducted to evaluate the impact of BCO2 on 
mitochondria. Metabolomics results revealed striking metabolic changes between 
genotypes. The top ranking metabolites in distinguishing WT and BCO2-/- mice 
suggested key differences in transport of long chain fatty acids into mitochondria, 
biosynthesis of bile acids; metabolism of sulfur-containing amino acids; and markers of 
inflammation. The significantly lower long chain fatty acids and glucose in the 
hypothalamus may regulate energy homeostasis by altering nutrient sensing. Within the 
mitochondria, altered pathways including the proteins involved in Krebs cycle, electron 
transport chain and fatty acids β-oxidation were observed in hypothalamic mitochondria 
of BCO2 -/- mice. The deletion of BCO2 also led to the significantly decreased capacity 
of complex II of electron transport chain. In conclusion, the absence of BCO2 may be 
closely associated with hypothalamic metabolism disorder and mitochondrial dysfunction 
caused by the perturbed energy utilization. The significantly lower leptin level and lower 
hypothalamic glucose and lipids sensing may be the major contributor to the enhanced 
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Obesity has emerged as one of the most serious health issues in the world, which is 
closely related to type-2 diabetes [1], neurodegenerative diseases [2], cardiovascular disease [3], 
and some forms of cancer [4, 5]. Obesity is the result of energy intake exceeding energy 
expenditure. It is a disorder of energy balance [6] commonly caused by a combination of 
excessive food intake, lack of physical activity, and genetic susceptibility [7].  
The hypothalamus is a key region in the brain for modulating feeding behavior and 
energy expenditure through nutrient sensing and signal integration from central and peripheral 
pathways [8-10].Two populations of neurons in the arcuate nucleus (ARC) of the hypothalamus 
play an important role in maintaining energy balance. One population of neurons express 
anorexigenic proopiomelanocortin (POMC) and the other express orexigenic agouti-related 
protein (AgRP)/neuropeptide Y (NPY). POMC and NPY/AgRP neurons could respond to leptin 
and insulin and interact with gut hormones such as ghrelin, glucagon-like peptide-1 (GLP-1), 








Hypothalamic mitochondria are involved in the modulation of energy balance by 
mitochondrial dynamic to modulate AGRP and POMC neuronal activity [12, 13]. Mitochondria 
could change their number and size by fusion and fission to adapt to the energy environment [12]. 
It was reported that mitochondria could fuse in AgRP neurons, and fission in POMC neurons 
during a positive energy balance to enable sustained neuronal activity and maximize the uptake of 
energy. The morphology of mitochondria also differs between obese and lean mice. Reduced 
mitochondrial length and loss of mitochondria-endoplasmic reticulum (ER) interactions were 
observed in diet-induced obese mice compared to lean controls [13].  
The mitochondria are responsible for most of the ATP production in the cell through the 
electron transport chain (ETC)/oxidative phosphorylation (OXPHOS). These processes occur in 
the inner membrane of mitochondria. The ATP producing capacity of mitochondria is another 
factor that affects energy homeostasis. Reduced ATP level in the hypothalamus leads to persistent 
AMPK stimulation. Leptin could function through inhibition of hypothalamic AMPK signaling to 
increase energy expenditure and lower food intake. Therefore, sustained AMPK stimulation 
requires a high level of leptin to suppress the effects of AMPK on AgRP and NPY [14]. Such 
impairment in ATP formation would lead to the tendency of eating more than what the body 
needs and conserving energy by lowering energy expenditure.  
BCO2 (β, β-carotene-9’,10’-oxygenase2) is an enzyme that catalyzes the asymmetric 
cleavage of carotenoids in the inner membrane of mitochondria [15]. Recent controversial 
research findings demonstrated that BCO2 may not be activated in the human macula where 
carotenoids preferentially accumulate [16, 17], suggesting that BCO2 may not only function as a 
carotenoid cleavage enzyme which warrants further investigation. For example, BCO2 is 





participates in macular degeneration in humans [16] and in the process of anemia and apoptosis 
of red blood cells in zebrafish [19]. Furthermore, BCO2 protein expression is reduced in obese 
[20] and diabetic mice [21]. However, how BCO2 impacts these processes, whether in a direct or 
an indirect manner, is still unknown.    
The expression and activity of BCO2 have been verified in humans [22], mice [23], rats 
[24], cattle [25], chickens [26], and sheep [27]. BCO2 is expressed in many types of cells, such as 
liver hepatocytes, epithelial cells of villi and endothelial cells in the duodenum, and other tissues 
such as kidney and lungs [28-30]. Recently, BCO2 was found to be in the inner mitochondrial 
membrane [31], where complexes of the ETC/OXPHOS are located. In accordance with this 
finding, carotenoids were found to be accumulated in the mitochondria of BCO2 knockout mice, 
which further led to mitochondrial dysfunction, indicated by an increased manganese superoxide 
dismutase (MnSOD) level and decreased respiratory activity [23]. Given that the key position of 
the hypothalamus in energy balance and the potential role of BCO2 in mitochondrial function, 
BCO2 may play a novel function in maintaining metabolic homeostasis in the hypothalamus. 
Therefore, we hypothesize that BCO2 contributes to hypothalamic mitochondrial function 
through its impact on the ETC/OXPHOS. Complete ablation of BCO2 will elevate oxidative 
stress, perturb energy metabolism, and impair cell signaling in hypothalamus. The following four 
specific objectives have been developed to test the hypothesis. 
Objective 1:    To characterize the impact of BCO2 on blood parameters, such as fasting  
  glucose, lipid profile and circulating leptin, insulin and glucagon level; 
Objective 2:    To elucidate the impact of BCO2 on the hypothalamic global metabolic status; 
Objective 3:    To profile the change in hypothalamic mitochondrial proteome in wild-  
type (WT) and BCO2-/- mice; and 





(basal respiratory activity, proton leak, ATP production, and capacity of ETC 










This literature review includes an overview of the energy homeostasis at the 
hypothalamic and mitochondrial level, as well as the role of BCO2 in mitochondrial function. 
1. Predominant role of hypothalamus in mediating energy homeostasis 
Obesity refers to the metabolic state in which excess fat is accumulated in peripheral 
tissues, such as white adipose tissue, liver, and muscle [32]. Obesity, which has negative effects 
on both the quality and length of life, is commonly caused by a combination of excessive food 
intake, lack of physical activity, and genetic susceptibility [7, 33]. The hypothalamus plays a 
significant role in controlling energy expenditure and food intake, which are the determinants of 
metabolic phenotype. 
The hypothalamus is organized into anatomically discrete nuclei: paraventricular nucleus 
(PVN), lateral hypothalamic area (LHA), dorsomedial hypothalamic nucleus (DMH), 
ventromedial hypothalamus (VMH), and ARC [34]. These neuronal clusters form interconnected 
neuronal circuits to sense information inputs from the process of eating, ingestion, absorption, 





experiments showed that LHA acts as the “hunger center” and is associated with hypophagia and 
loss of body weight, while the VMH is the ‘satiety center’ and is linked to hyperphagia and 
obesity [35]. The ARC is located in the basal part of the hypothalamus and is in close contact 
with the median eminence. The ARC could sense fluctuations in signals from hormones, 
nutrients, and other molecules that are transported within the blood [8]. Thus the ARC has been 
postulated to play a fundamental role in sensing the global energy status of the organism [8, 9] 
and integrating signals from central and peripheral pathways [10].  
The POMC and AgRP/NPY are expressed by two key populations of neurons that have 
opposite effects on appetite in the ARC. POMC neurons exert an anorexigenic effect by co-
expressing POMC and cocaine- and amphetamine-regulated transcript (CART) [34]. POMC is 
the precursor of α-melanocyte stimulating hormone (α-MSH), which could activate melanocortin 
4 receptors (MC4R). Activation of MC4R would ultimately inhibit appetite and increase energy 
expenditure [36]. The other population of neurons co-express orexigenic NPY and AgRP. NPY 
exerts an orexigenic effect via different subtypes of NPY receptors on downstream neurons, while 
AgRP could directly block α-MSH action [36]. Both of these populations of neurons act on the 
PVN, and the ARC also interacts with other hypothalamic nuclei such as the LHA, VMH, and 
DMH [37].  
1.1. Hypothalamus regulates energy homeostasis via circulating hormones 
NPY/AgRP and POMC/CART neurons respond to a variety of circulating hormones to 
regulate energy balance. Insulin and leptin are the two most critical anorexigenic hormones that 
are involved in energy homeostasis [38]. The activation of leptin and insulin are mediated by their 
receptors in the central nervous system (CNS). Leptin receptor (LepR) and insulin receptor (InsR) 





Leptin is a hormone secreted from white adipose tissue and circulates through the body in 
proportion to body fat mass. It plays a major role in energy homeostasis by inhibiting food intake, 
enhancing lipolysis, decreasing lipogenesis, and elevating energy expenditure. Leptin acts via 
LepR in the hypothalamus (predominantly the VMN and ARC, but also the choroid plexus) to 
regulate energy balance and neuroendocrine function [40-42]. The POMC neurons are activated 
by leptin, resulting in α-MSH release from POMC axon terminals. The α-MSH could further 
activate MC4R to increase energy expenditure and suppress food intake [43]. At the same time, 
the activity of NPY/AgRP neurons is inhibited by leptin [44]. Otherwise, it would antagonize the 
effect of α-MSH on MC4Rs through the release of AgRP [45]. Besides the actions of leptin via 
the brain, energy expenditure and food intake could also be modified through the direct action of 
LepRs on a peripheral target, including the β cells of the pancreas, liver, muscle, and fat [46]. 
 Insulin is secreted by pancreatic β-cell in response to increased plasma glucose levels. It 
promotes energy utilization and storage through the regulation of glucose uptake and the 
metabolism of fatty acids. In skeletal muscle, insulin promotes glucose uptake by stimulating the 
movement of intracellular vesicles containing GLUT4 from cytosol to the plasma membrane, 
which increases the transport capacity for glucose. In adipose tissue, insulin reduces free fatty 
acid (FFA) efflux from adipocytes, thus decreasing lipolysis and facilitating fat storage. 
Furthermore, insulin promotes the storage of glucose as glycogen and/or triacylglycerol in the 
liver and inhibits hepatic glucose production by decreasing the activity of gluconeogenic enzymes 
[47].  
Hypothalamic leptin and insulin signaling are involved in both short- and long-term 
energy regulation (Fig. 1 (revised from [9])). Janus kinase (JAK) is recruited and activated when 
leptin binds to the extracellular domain of LepR-b. The activated JAK in turn helps to 





transcription 3 (STAT3) are activated. The phosphorylated STAT3 could stimulate POMC and 
inhibit AgRP [49]. The activation of STAT3 is associated with the elevated expression of the 
suppressor of cytokine signaling 3 (SOCS3). SOCS3 will bind with the LepR-b-JAK-2 complex, 
thus inhibiting leptin signaling [50]. Insulin signaling is initiated by insulin binding to the α 
subunit of InsR [51]. The conformational change of the α subunit exhibits intrinsic tyrosine 
kinase activity, which could activate InsR [52]. The insulin receptor substance (IRS) is activated 
through the phosphorylation process resulting from InsR. The leptin signaling and insulin 
signaling converge together through the phosphoinositide 3-kinase (PI3K) – Phosphatidylinositol 
3,4,5-trisphosphate (PIP3)– 3-phosphoinositide-dependent protein kinase 1(PDK1) – forkhead 
box protein O1 (FoxO1) signaling pathway [9]. The PI3K, which is activated by leptin or IRS, 
could promote the synthesis of PIP3 [53]. As the PIP3 accumulates, PDK1 is activated, which 
leads to the activation of protein kinase B (PKB, also known as AKT). Within the nucleus, 
FoxO1 could activate AgRP and inhibit POMC expression [54]. Activation of AKT induces the 
phosphorylation of FoxO1 and further leads to the export of FoxO1 into the cytoplasm. This 
would facilitate STAT3 to bind with POMC/AgRP. AKT also functions to activate the 
mammalian target of rapamycin (mTOR), and the activation of mTOR involved in 
phosphorylation and inhibition of adenosine monophosphate (AMP)-activated protein kinase 
(AMPK). Both mTOR and AMPK act as sensors of the nutrient status that is involved in the 







Fig. 1 Leptin and insulin signaling pathway in the hypothalamus (Revised from [9]) . Leptin 
and insulin are secreted from white adipose tissue and the pancreas, respectively. Leptin and 
insulin activate their receptors in the hypothalamus. Both of the activation of LepR‐b and InsR 
could further activate PI3K–PIP3–PKD1–FoxO1 signalling pathway. Phosphorylation of LepR-b 
by JAK2 also leads to the recruitment and phosphorylation of STAT3. SOCS3 would desensitize 







Most obese patients have high serum leptin levels leading to leptin resistance. Similarly, 
insulin resistance is characterized by a decreased ability to respond to insulin. In most cases, 
impaired insulin sensitivity of the target organs, rather than the low insulin level in the body, 
eventually leads to type 2 diabetes. Activation of the IκB kinaseβ (IKK), c-Jun N-terminal kinase 
(JNK), and protein kinase C iota (PKCτ) signaling pathways and increased expression of SOCS3 
and PTP1B are the major molecular mechanisms involved in the induction of hypothalamic leptin 
resistance and insulin resistance [55-59].  
The hypothalamus can also interact with a variety of gut hormones. For example, peptide 
YY3–36, cholecystokinin, GLP-1, oxyntomodulin (OXM), and pancreatic polypeptide act 
synergistically to suppress appetite, whereas ghrelin acts to stimulate food intake [10, 11]. By 
relaying signals of nutrient level and energy status in the gut to the CNS, the interaction between 
NPY/AgRP and POMC/CART neurons and gut hormones plays a critical role in regulating food 
intake.  
1.2. Hypothalamus regulates energy balance via sensing nutrient status 
Aside from the signals from hormones, the hypothalamus is also sensitive to circulating 
metabolites. Two types of glucosensing neurons are either inhibited or excited as glucose level 
fluctuates [60]. Glucosensing neurons regulate their membrane potential, firing rate, and ion 
channel function to sense ambient glucose. Glucose sensing is especially important in stimulating 
appetite when glucose availability drops [61-63].   
Circulating lipids such as triglyceride and long-chain fatty acids (LCFAs) function 
similar to insulin through elevation of the LCFA-CoA level in the hypothalamus [64]. LCFA gets 
into the brain cells by passive diffusion [65] or translocation via a carrier protein [66]. In the 
diffusion model, fatty acids diffuse across the luminal and transluminal leaflets of endothelial 





protein transporters expressed on cell membrane, such as fatty acid tanslocase/CD36, fatty acid 
transport protein (FATP) 1-6, and plasma membrane fatty acid binding protein are involved in the 
transport of fatty acid into the blood brain barrier [66, 68, 69]. Upon entry into the neurons, 
LCFA is esterified into LCFA-CoA via Acetyl-CoA synthetase (ACS). LCFA-CoA signals 
nutrient abundance and exhibits insulin-like effects in the brain, including the hypothalamic ARC, 
to modulate energy homeostasis [70]. Brain fatty acids act as a satiety signal to inhibit appetite 
[71]. Both the peripheral and central administration of a fatty acid synthase inhibitor significantly 
suppresses appetite [72, 73]. An in vivo study showed food intake and hepatic glucose production 
were inhibited after three days of intracerebroventricular infusion of oleic acid [74]. The 
accumulation of LCFA-CoA within specific CNS neurons could activate catabolic neural 
pathways to inhibit appetite and hepatic glucose production [75]. The anorectic effect of LCFA-
CoA accumulation may lie downstream of the leptin-induced inhibition of hypothalamic AMPK 
[76]. LCFA-CoA in the brain activates protein kinase C and further phosphorylates and activates 
ATP-sensitive potassium (KATP) channels. This lipid-sensing pathway in the hypothalamus 
activates N-methyl-d-aspartate (NMDA) receptor to trigger the hepatic vagus nerve to regulate 
glucose production. In this way, neuronal signals are transmitted via the hepatic vagus nerve to 
the liver.  
In contrast to intracellular LCFA-CoA accumulation, which is a sensor of nutrient 
abundance, the AMPK is a sensor of nutrient insufficiency. At the peripheral level, AMPK 
activation leads to increased oxidation to maintain cellular energy availability. In the ARC, 
AMPK activation results in increased food intake and a trend to conserve energy [77]. When cells 
sense the low fuel availability indicated by an increased AMP/ATP ratio, the activation of AMPK 
enhances substrate oxidation to replenish the depleted ATP levels [70]. Research conducted in 
mice showed that within the mediobasal hypothalamus, activation of AMPK increased food 





AMPK activity is inhibited by glucose, insulin, and leptin and stimulated by ghrelin [77, 78]. The 
change in AMPK signaling may also alter the appetite governed by these hormones. A 
consequence of increased AMPK activity is the oxidation of LCFA-CoA, which might induce 
orexigenic effects. Furthermore, AMPK could inhibit the activity of mTOR, another nutrient 
sensor, which will be discussed below.  
mTOR is an evolutionarily conserved serine-threonine kinase involved in the regulation 
of cell-cycle progression and growth via sensing energy status [79]. It was demonstrated that in 
peripheral tissues, mTOR participates in coupling cellular energy status and facilitated cellular 
anabolic processes, such as protein synthesis in response to growth factors, amino acids, glucose, 
and stress [10]. Later, research found that mTOR was also expressed in the hypothalamus and 
play an important role in hypothalamic regulation of energy homeostasis in response to nutrient 
availability. Cota et al. found that administration of leucine in rats led to elevated hypothalamic 
mTOR signaling and decreased food intake, as well as body weight [79]. They also showed that 
leptin could activate hypothalamic mTOR activity and that inhibition of mTOR signaling would 
block the leptin-induced suppression of food intake [79]. Both mTOR and AMPK represent a 
potential site of convergence for both hormonal and nutrient sensing.  
2. The role of mitochondria in maintaining cellular energy metabolism 
We have discussed that the hypothalamus is the most important organ to modulate energy 
homeostasis in brain. When we take a closer look at the cell organelle level, the mitochondrion is 
the key organelle that maintains cellular energy metabolism. The mitochondrion is a double-
membrane bound organelle in most eukaryotic cells [80]. It is composed of an outer membrane, 
intermembrane space, inner membrane, and the matrix. Variety of enzymes are involved in 
different metabolic processes in the mitochondrial matrix. One major role of a mitochondrion is 





the utilization of the carbohydrate-derived substrate, the β-oxidation of fatty acids is another 
resource to generate ATP that mainly takes place in the mitochondria. Besides providing a 
platform for the oxidation of fuel substrates, mitochondria are also involved in a variety of cell 
signaling pathways by acting as transducers and effectors in the process of cell death, innate 
immunity, and autophagy [81, 82]. Furthermore, mitochondria also serve as calcium buffers and 
sources of free radicals [83, 84].  
2.1. Hypothalamic mitochondria and energy homeostasis 
Hypothalamic mitochondrial dynamic is involved in the energy homeostasis through the 
regulation of AgRP and POMC neuronal activity [12, 13]. Mitochondrial dynamics refer to the 
dynamic fission and fusion behavior and morphology change of mitochondria [85] in response to 
the environment, especially to the energy status. Mitofusins (Mfn), namely Mfn1 and Mfn2, work 
coordinately to regulate mitochondrial fusion. The depletion of Mfn1 and Mfn2 in AgRP neurons 
of mice led to decreased activity of the AgRP neuron, which was accompanied by weight loss. 
[12]. When mice were deprived of food, an increased number and decreased size of mitochondria 
were observed in AgRP neurons [12]. When fasted mice were exposed to excess food, the 
number of mitochondria decreased but their size increased in the AgRP neurons. However, the 
opposite fission-like dynamic phenomenon was observed in the POMC neurons, which exhibited 
reduced mitochondrial density and coverage [12]. Similarly, mitochondria in the AgRP neurons 
were fused when mice were fed a high-fat diet. These findings indicate that mitochondria could 
fuse in AgRP neurons and fissure in POMC neurons during a positive energy balance to enable 
sustained neuronal activity and maximize the uptake of energy. 
The morphology of mitochondria also differs between obese and lean mice. It has been 
reported that mitochondrial networks and mitochondria-endoplasmic reticulum (ER) contacts in 





organelles that often branch and form connections with each other through tubular reticulum [86].  
Such branched structure of the mitochondrial network is constituted by separate mitochondria 
[87]. Decreased mitochondrial length and branching was observed in diet-induced obese mice 
compared to lean controls. Diet-induced obese mice also showed a significant reduction of 
mitochondria-ER contacts in POMC neurons. 
2.2. Mitochondria and adipocyte transcription factors  
Some adipocyte transcription factors play a critical role in modulating mitochondrial 
function and biogenesis [88]. The peroxisome proliferator-activated receptor gamma coactivator 
(PGC) family is a group of transcriptional coactivators. A reduced PGC-1α level was observed in 
the adipose tissues of obese patients [89] and in genetically or diet-induced obese mice [90]. 
PGC-1α and PGC-1β not only participate in the regulation of glucose metabolism, fatty acid 
metabolism, and lipid accumulation, but also function to affect the expression of the 
mitochondrial biogenesis gene and are involved in the development of obesity [91]. PGC-1 
stimulates mitochondrial biogenesis and respiration in myotubes of muscle via an induction of 
uncoupling protein 2 (UCP2), and through the regulation of the nuclear respiratory factors 
(NRFs). Deficiency in either PGC-1α or PGC-1β in preadipocytes of brown adipose tissue (BAT) 
led to impaired mitochondrial gene expression, density, and respiratory activity [92] . 
PR Domain Containing 16 (PRDM16) is the coactivator of PGC-1α and PGC-1β, which 
is important for mitochondrial biogenesis and uncoupled cellular respiration [93, 94]. Decreased 
PRDM16 expression in BAT leads to the inhibition of mitochondrial gene expression and 
stimulation of myogenic markers [94, 95]. Another important transcriptional coactivator is bone 
morphogenetic protein 7 (BMP7), a subgroup of the transforming growth factor beta (TGF-β) 





biogenesis genes through activation of p38 mitogen-activated protein kinases (MAPK) and PGC-
1α [96]. 
3. Mitochondrial dysfunction in the development of obesity  
A renaissance in mitochondrial research has occurred during the past decade. Besides its 
function in energy production, mitochondria participate in many processes including cell 
signaling, cell differentiation, and apoptosis [87]. Mitochondria are also involved in the 
generation of reactive oxygen species (ROS), ER stress, and inflammation. Mitochondrial 
dysfunction is thought to trigger many chronic diseases, including neurodegenerative diseases 
such as Parkinson’s disease and Alzheimer’s disease, liver and kidney disorders, diabetes, and the 
aging process [97]. By integrating metabolic information including ATP level, oxidative stress, 
ER stress, inflammation, and cell signaling, mitochondria play an important role during the 
development of obesity. 
3.1. Inadequate ATP production and obesity 
A possible source of leptin resistance is impaired mitochondrial ATP production. 
Research has shown that altered mitochondrial energy production, especially in skeletal muscles, 
is a major factor to disrupt a chain of metabolic events leading to obesity [14]. In the 
hypothalamus, the reduced energy producing capacity of mitochondria led to persistently high 
hypothalamic AMPK stimulation. Leptin could function through inhibition of hypothalamic 
AMPK signaling to increase energy expenditure and lower food intake. Therefore, sustained 
AMPK stimulation requires a high level of leptin to suppress the regulation of AMPK on AgRP 
and NPY [14]. Such impairment in ATP formation would lead to the tendency of eating more 
than what the body needs and conserving more energy by lowering energy expenditure. 





In the mitochondria, energy is produced from the TCA cycle, ETC/OXPHOS, and β-
oxidation of fatty acids. Approximately 90% of oxygen in the cell is consumed by the 
mitochondria [98]. The mitochondrial respiratory chain is one of the major sources of ROS. 
While mitochondria generate ATP through ETC/OXPHOS, ROS is generated as a byproduct 
[99]. The electrons are transported from NADH and FADH2 to complex III, and then to complex 
IV. Eventually, electrons are passed on to oxygen, yielding H2O. However, some electrons might 
escape from ETC. Once these electrons leak into the mitochondrial matrix, the incomplete 
electron transfer will lead to the formation of superoxide (O2−⋅). It has been reported that complex 
I is a major donor of electrons to generate ROS in the brain [100]. Even under normal 
physiological conditions, approximately 1–5% of the O2 consumed by mitochondria is converted 
to ROS [87]. ROS refer to a variety of oxygen free radicals, such as superoxide anion radical 
(O2−⋅), hydroxyl radical (·OH), and non-radical oxidants, such as hydrogen peroxide (H2O2) and 
singlet oxygen (1O2) [101]. Most of the intracellular ROS are derived from superoxides.   
ROS are important for various cell functions and act as a mediator of intracellular 
signaling cascades. However, excessive production of ROS may cause damage to cells and 
ultimately lead to the apoptosis or necrosis of the cells [102]. Organisms need to maintain 
equilibrium between the ROS produced during the energy generating process and the damaging 
effects of ROS, which is known as oxidative stress [87]. Oxidative stress is usually associated 
with the etiology of obesity, type 2 diabetes, cancer, and many other chronic diseases [103, 104]. 
In the cells, there are various anti-oxidative enzymes, such as superoxide dismutase, copper/zinc 
superoxide dismutase, glutathione peroxidase, and catalase, to deal with the continuous 
production of ROS [105]. 
The excess lipid accumulation in obese individual represents an excess of energy, but 





deficiency [14]. Continuous mitochondrial overload of fuel and incomplete fatty acid oxidation 
could lead to increased ROS production [106, 107]. Oxidative stress also impairs mitochondrial 
function, resulting in elevated ROS production and mitochondrial dysfunction. This 
mitochondrial dysfunction may in turn induce insulin resistance, resulting in a vicious cycle that 
leads to obesity-related pathogenesis. The elevated ROS level due to mitochondrial dysfunction 
stimulates various downstream pathways including JNK/signal transducers and activators of 
transcription (STAT) pathway, JNK/ inhibitor of nuclear factor kappa-B kinase (IKKβ), and 
MAPK, which can disturb leptin and insulin pathways [52, 108-110]. A decreased number of 
mitochondria may also lead to insulin resistance [52]. Petersen and colleagues demonstrated that 
insulin resistance is caused by dysregulation of cellular fatty acid metabolism, which is a result of 
an inherited defect in mitochondrial oxidative phosphorylation [111]. 
3.3. ER stress and obesity 
ER, an important organelle that forms an interconnected network, is responsible for the 
synthesis, folding, and maturation of secreted and transmembrane proteins; biosynthesis of lipids; 
and the storage of Ca2+ [112, 113]. ER stress results from an imbalance between the protein 
folding capacity and the protein load [55]. The direct result of ER stress is the accumulation of 
misfolded protein. The ER establishes direct contact with mitochondria through ER domains 
termed mitochondrial-associated membranes (MAMs). MAMs allow bidirectional 
communication and trafficking of a signaling molecule [114]. Such association is essential for 
both mitochondria and ER functions. The interaction between the ER and mitochondria is 
partially modulated by mitochondrial fusion and fission [114]. The dysfunction of mitochondria 
is one trigger to ER stress through decreased ATP production and the alteration of the 
mitochondrial membrane potential and permeability. Both diet-induced and genetic obesity in 





ER stress has emerged as a causative factor in the development of obesity by inducing leptin 
resistance and insulin resistance. 
 Enhanced hypothalamic ER stress may play a primary pathogenic role in the 
development of leptin resistance. Schneeberger et al. put forward the hypothesis that MFN2 in the 
POMC is the molecular link between hypothalamic ER stress and leptin resistance [13]. To 
explore whether inhibition of ER stress could reverse the sensitivity of leptin, different 
approaches aimed at alleviating hypothalamic ER stress were conducted. Diet induced obese mice 
were treated with chaperones 4-phenylbutyrate (4-PBA) or tauroursodeoxycholic acid (TUDCA). 
The results showed normalization of the expression of ER stress, accompanied by enhanced leptin 
sensitivity and reduced food intake and body weight [56, 115-118]. Furthermore, ER stress 
inducing reagents could inhibit leptin signaling by blocking the phosphorylation of STAT3 [119]. 
Research also found that ER stress leads to leptin resistance via the mediation of protein tyrosine 
phosphatase 1B (PTP1B) [118].  
Besides leptin resistance, ER stress may induce insulin resistance as well. The activation 
of JNK by ER stress could lead to increased serine phosphorylation of IRS. Phosphorylation of 
IRS at particular serine residues will disturb the interaction of IRS with InsR [120]. In addition, 
ER stress in pancreatic β-cells leads to β-cell apoptosis [121]. ER stress could also induce 
leptin/insulin resistance through elevated inflammation in the hypothalamus [55]. The mechanism 
of inflammation during the development of obesity will be discussed in the following section. 
3.4. Hypothalamic inflammation and obesity 
Continuous excessive nutrient exposure of the mitochondria could activate inflammatory 
pathways both in peripheral metabolic organs and in the CNS. Hypothalamic inflammation is 
characterized by increased interleukin and cytokine levels. For example, increased expression of 





well as the elevated expression of IKKβ, an important upstream kinase regulator of nuclear factor 
kappa–B (NF-κβ), were observed in the hypothalamus of obese rats [122, 123].  
Both lipid infusion and high-fat diet feeding could lead to obesity by activating 
hypothalamic inflammatory signaling pathways, which results in enhanced food intake and 
increased nutrient storage. Saturated fatty acids activate neuronal JNK and NF-κB signaling 
pathways, which directly impact leptin and insulin signaling [56]. The neuronal pro-inflammatory 
signaling could disturb intracellular signal transduction downstream of insulin receptors through 
the IRS phosphatidylinositol 3-kinase pathway [124]. Hypothalamic inflammation impairs leptin 
signaling via the JAK/STAT signaling pathway [125, 126] and induces obesity by up-regulating 
molecules and pathways including an inhibitor of IKKβ, serine kinases, JNK, toll-like receptor 4 
(TLR4), the ceramide biosynthesis pathway, and/or the ER stress pathway [127, 128]. The 
induction of hypothalamic inflammation is associated with the activation of toll-like receptor 
(TLR) signaling [127]. Enhanced TLR expression activates JNK and IKK signaling and 
stimulates expression of inflammatory genes, such as TNFα and IL1β, which may be the main 
contributors to leptin resistance and insulin resistance. When TLR4 signaling was blocked, leptin 
resistance and insulin resistance were reversed [127].  
4. Carotenoids, BCO2, and mitochondrial function 
 Carotenoids are a group of fat-soluble pigments derived from a 40-carbon base structure. 
Based on the chemical structure, carotenoids can be categorized into two classes: (1) carotenes, 
which contain only carbon and hydrogen atoms, and (2) oxocarotenoids (xanthophylls), which 
carry at least one oxygen atom [129].  
Carotenoids are crucial for brain and visual function. Lutein and zeaxanthin are dominant 





the brain [130, 131]. They are also believed to prevent damage that leads to age-related macular 
degeneration by quenching free radicals and absorbing blue light [132, 133]. Significant 
correlation between macular pigment density and global cognitive function was found in older 
adults [134, 135]. It was reported that macular lutein and zeaxanthin were significantly correlated 
with their levels in brain tissue [136]. Therefore, macular pigment can also be used as a 
biomarker of lutein in brain tissue [137]. The brain is vulnerable to free radical attack because of 
the high metabolic activity, and high polyunsaturated fatty acid content. Lutein and zeaxanthin 
are the predominant carotenoids that are selectively taken up by human brain tissue and play an 
important neuro-protective role in brain function [138]. The most well-known benefit of 
carotenoids in brain is improvement of cognitive function [137]. These carotenoids have also 
been suggested to modulate functional properties of synaptic membranes and to be involved in 
certain changes in the physiochemical and structural features of the membranes [139]. Most of 
these functions are attributed to their anti-oxidative and anti-inflammatory properties [137].  
Considering the critical roles of carotenoids in brain function, a well-regulated 
metabolism of carotenoids is necessary for brain, as well as the whole body health. BCO2 is a 
mitochondrial enzyme involved in the cleavage of carotenoids. Compared to β-carotene-15, 15’-
monooxygenase (BCO1), BCO2 exhibits broader substrate specificity. It catalyzes asymmetric 
cleavage of both provitamin A and non-provitamin A carotenoids at the 9’, 10’ double bond to 
form β-ionone and β-apo-10’-carotenal [15]. The metabolites of carotenoids also exhibit 
important biological function such as the activation of the NF-κB transcription system which is 
associated with harmful effect to bone health, and contributes to cancer development. The 10,10′-
diapocarotene-10,10′-dial, which is the cleave products of lycopene by BCO2, was reported to 
inhibit NF-κB transcription system and to reduce the expression of NF-κB target genes [140]. 
Such process was mediated by the direct interaction of carotenoid derivatives with key kinases 





carotenoid exhibited inhibitory effect on NF-κB highlights the critical role of BCO2 in providing 
the health benefits of carotenoids. 
Previously, most research related to BCO2 was focused on the enzymatic function of 
BCO2. For example, Amengual et al. reported the deletion of BCO2 led to the disrupted 
carotenoid homeostasis accompanied by the elevated oxidative and reduced respiratory activity 
when mice were fed with diets rich in carotenoids [23]. However, our recent studies found that 
deletion of BCO2 gene in mice leads to increased appetite and higher risk of obesity, even when 
mice were fed with chow diet or high fat diet without carotenoids. This observation brings the 
possibility that BCO2 may play a more complicated role in maintaining mitochondrial function to 
modulate whole body energy homeostasis, rather than just exhibiting enzymatic function. The 
proteomics and metabolomics analysis from our laboratory further revealed perturbed energy 
metabolism, mitochondrial dysfunction, and elevated oxidative stress in hypothalamus caused by 
deletion of BCO2. 
Conclusion and perspectives 
The hypothalamus and mitochondria are two important centers for regulation of energy 
homeostasis at the organ and organelle levels, respectively. As the key organelle that maintains 
cellular energy metabolism, hypothalamic mitochondria participate in a variety of cell signaling 
pathways and modulate energy homeostasis through mitochondrial dynamics. Mitochondria is 
involved in the development of obesity via inadequate ATP production, enhanced inflammation, 
elevated oxidative stress, and ER stress. Therefore, the mitochondrial integrity is critical for 
energy homeostasis of the whole body and hypothalamus. Carotenoids have been recently 
characterized in brain. However, the functions of carotenoids and the metabolites in 





Considering the potential role of BCO2 in mitochondrial structure and function and the 
key position of the hypothalamus in energy balance, BCO2 may play a novel function in 
maintaining metabolic homeostasis in hypothalamus through regulation of mitochondrial 
dynamics. However, the exact mechanism by which BCO2 mediates mitochondrial dynamics and 
hypothalamic function in regulating energy balance remains unknown. Elucidating how BCO2 
and the carotenoid metabolites protect mitochondrial activity and subsequent contribution to 
maintaining hypothalamic function will provide new perspectives for the prevention and 









ALTERED LIPID METABOLISM REMODELS HYPOTHALAMIC METABOLOME TO 
STIMULATE FEEDING BEHAVIOR IN BCO2-/- MICE 
 
1. Introduction 
 Excess food intake is a major contributor to the high incidence of obesity, which has 
emerged as a serious health issue around the world. Such feeding behavior requires a coordinated 
effort of neurotransmitters, peptides, and hormones in various nuclei throughout the brain [141]. 
The hypothalamus is a key brain region for modulating feeding behavior through signal 
integration from central and peripheral pathways. Two functionally distinct populations of 
neurons, which express POMC and AgRP/NPY, could respond to a variety of circulating 
hormones to regulate both short- and long-term energy homeostasis [38].  
 Glucose, amino acid, and fatty acid all function as signaling molecules which can be 
detected by the hypothalamus to modulate feeding behavior [9]. There are two types of 
glucosensing neurons that are either inhibited or excited as glucose level fluctuates [60]. 
Glucosensing neurons regulate their membrane potential, firing rate, and ion channel function to 





glucose availability drops [63]. Some amino acids, especially branched chain amino acids 
(BCAAs), may also produce signals relevant to food intake and protein balance [142]. The 
administration of leucine into mediobasal hypothalamus suppressed food intake [143]. The 
injection of BCAAs metabolites, such as α-ketoisocaproic acid, or α-ketoisovaleric acid into 
mediobasal hypothalamus lead to reduced food intake and body weight [143]. There is also 
increasing evidence indicating fatty acid sensing as important contributor in the regulation of 
feeding behavior, energy utilization, and storage [144]. Brain fatty acids act as a satiety signal to 
inhibit appetite [71]. Both the peripheral and central administration of fatty acid synthase 
inhibitor significantly suppressed appetite [72, 73]. In vivo study showed that food intake and 
hepatic glucose production was inhibited after three days intracerebroventricular infusion of oleic 
acid [74]. LCFA, such as oleic acid, might activate POMC neurons via the inhibition of KATP 
channel activity [145].  
 The carotenoids, carotenoid-derived products, and carotenoids-cleavage enzymes are 
reported to be involved in lipid metabolism, adipocyte biology, and fat accumulation [146]. Two 
enzymes are involved in the cleavage of carotenoids. β, β-carotene-15’,15’-oxygenase1 (BCO1) 
catalyzes the conversion of β-carotene into retinaldehyde; and β, β-carotene-9’,10’-oxygenase2 
(BCO2) into β-10’-apocarotenal and β-ionone [147]. These compounds were reported to reduce 
adiposity by affecting adipocyte differentiation [148], hypertrophy [146], basal lipolysis, fatty 
acid oxidation [149], thermogenesis [150], and secretory function [146]. The administration of β-
carotene to wild type mice significantly reduced adipose tissue weight and adipocyte size [147]. 
The expression of peroxisome proliferator-activated receptor γ (PPARγ) was found to be 
decreased at both mRNA and protein level [147] in wild type mice. However, these effects were 
not observed in BCO1 knockout mice, which indicated the critical role of carotene-cleaved 





triacylglycerol, cholesteryl ester, phosphatidylinositol, and ceramide in the brain of BCO1 
knockout embryos [151] also reveal the importance of BCO1 in lipid metabolism. 
Unlike BCO1, which is a cytosolic protein, BCO2 was found to be in the inner 
mitochondrial membrane [31], where complexes of the ETC/OXPHOS are located. Carotenoid 
homeostasis was disrupted in BCO2-/- mice, accompanied by the accumulation of carotenoids in 
the mitochondria [23]. This led to mitochondrial dysfunction as indicated by increased MnSOD 
level, elevated oxidative stress, and decreased respiratory activity [23]. Our previous study also 
showed that BCO2-/- mice exhibited higher food intake and were more prone to obesity. In 
addition, BCO2 protein expression was decreased in obese and diabetic mice [20, 21]. The aim of 
this study is to explore the mechanism by which BCO2-regulated lipid metabolism impacts 
hypothalamic metabolome and subsequent stimulation of feeding behavior. Here, plasma 
biomarkers of lipid metabolism, metabolomics profiling were utilized to investigate how 
hypothalamic metabolome were altered by BCO2 deletion. 
 
2. Methods 
2.1. Animals and animal care 
Male wildtype (WT) and BCO2-/- mice at six weeks of age were used in this study and 
group-housed (3 mice/cage) in a controlled environment with a 12-h/12-h light/dark cycle. Mice 
were fed a regular chow diet (CD, 13.4% kcal from fat, #5001; LabDiet, St Louis, MO). All mice 
had free access to water and food throughout the study. All animal protocols were approved by 
the Institutional Animal Care and Use Committee (IACUC) of Oklahoma State University. 
Hypothalamic tissues were collected for laboratory analysis.   





Blood samples from WT and BCO2-/- mice were collected and centrifuged for 20 min at 
2000 rpm at 4°C and stored at −80°C. The plasma non-esterified fatty acids (NEFA), triglyceride 
(TG), HDL, and LDL was quantitated using a Biolis 24i Analyzer (Carolina Liquid Chemistries, 
Winston-Salem, NC).  
2.3. Western blot analysis 
Protein samples prepared from  hypothalami [21] were separated by SDS-PAGE, 
transferred onto nitrocellulose membranes, and blocked in 5% nonfat milk for 1 hour followed by 
incubation in primary antibodies, including AKT, phospho-AKT, ACC, and β-actin (rabbit, 
dilution 1:1000, Cell signaling) overnight at 4 oC. Membranes were washed with PBS followed  
by incubation with secondary antibody, anti-rabbit IgG, HRP-linked Antibody (rabbit, dilution 
1:1000, Cell signaling). Immunoreactive bands were detected by chemiluminescence 
(SuperSignal Chemiluminescent Substrate; Thermo Fisher Scientific) and visualized using 
FluorChem  R System (ProteinSimple, USA). Protein expression level was normalized using β-
actin as loading control.  
2.4. Global metabolomic profiling 
To examine the functional impact of BCO2 on global metabolic phenotype in the 
hypothalamus of mice, the global metabolomic profiling was conducted by Metabolon, Inc 
(Durham, NC). The metabolites of hypothalamus samples from WT and BCO2-/- mice (6 
technical replicates for each genotype) were identified by ultra-high performance liquid 
chromatography-tandem mass spectroscopy (UPLC-MS/MS) and gas chromatography-mass 
spectroscopy (GC-MS).  





The metabolites identified in global metabolomic profiling with their p-value and fold 
change were uploaded to the IPA-Metabolomics platform [152]. This platform is capable of  
integrating proteomics and transcriptomics data to find significantly perturbed pathways, 
metabolic regulators, and novel biomarkers.  
2.6. Quantitation of cytokines expression level 
The Bio-Plex Mouse Diabetes 8-plex Panel assay kit (Bio-Plex Cytokine reagent kit, 
BIO-RAD Laboratories, Hercules, CA, USA) containing fluorescent microspheres conjugated 
with monoclonal antibodies were used to test the plasma insulin, glucagon, and leptin level 
between WT and BCO2-/- mice. Plasma samples were diluted four fold by adding 30μL serum 
and 120μL sample diluent. All procedures were performed following manufacturer’s instructions. 
Samples were incubated with antibody-coupled beads, biotinylated secondary antibodies, and 
streptavidin-phycoerythrin. Bead fluorescence intensity was detected by Bio-Plex MAGPIX 
multiplex reader (Bio-Rad, USA), and data analysis was performed with the Bio-Plex-Manager 
software (BIORAD Laboratories, Hercules, Calif., USA). 
2.7. Statistical analyses 
Data were presented as mean ± SD. For Global metabolomic profiling, Welch’s two-
sample t-test, matched pairs t-test, one-way ANOVA, and two-way ANOVA were used. 
Hotelling’s T2 test, random forest, and principal components analysis (PCA) were used for 
significance tests and classification analysis. The difference of plasma parameters level and 
protein expression level between genotypes were analyzed using student’s t-test. An estimate of 
the false discovery rate (q-value) is calculated to take into account the multiple comparisons that 






3.1. Impact of BCO2 on plasma lipids, glucose and hormones 
The plasma parameters of WT and BCO2-/- mice were listed in Table 1.  Both the fasting 
glucose and LDL increased significantly in BCO2-/- mice. The cholesterol and HDL level were 
significantly lower due to the deletion of BCO2. The insulin level did not change between two 
genotypes. However, the glucagon level decreased by 50.3%; and the leptin level decreased by 
74.1% in BCO2-/- mice compared to their age-matched WT mice. 
3.2. Global biochemical profiling  
Four hundred seventy seven metabolites from the hypothalamus of WT and BOC2-/- mice 
were identified and profiled. The detected metabolites including amino acid, lipid, carbohydrate, 
nucleotide xenobiotics, cofactors and vitamins (Fig. 2), covering 72 biochemical pathways. 
Among the 98 meatbolites that reach significant level between genotypes(p<0.05), 34 were 
significantly increased, while 64 metabolites were significantly decreased in BCO2-/-  mice.  
3.3. Random forest analysis  
Random forest classification was applied to assess the capacity to distinguish different 
genotype, as well as identify metabolite that is important to classify. The resulting models 
correctly classified the 12 hypothalamus samples from WT and BCO2-/- group with 100% 
predictive accuracy, which indicated genotypes displayed distinctive metabolic phenotypes. Mean 
decrease accuracy, which indicates how much a certain metabolite contributes to separation of the 
two test groups, was computed for each biochemicals. Significantly changed metabolites with the 
mean decrease accuracy above 10 were listed in Table 2. Metabolic signatures indicating changes 
in LCFA oxidation (oleoylcarnitine, stearoylcarnitine, oleate), bile acid synthesis and liver 
function (tauro-β-muricholate, cholate, taurocholate, deoxycholate and methyl glucopyranoside), 
indicators of oxidative stress (methionine, S-methylcysteine, taurine, ophthalmate, 4-hydroxy-





methylimidazoleacetate, kynurenine, stearoyl-arachidonoyl-glycerophosphoinositol, stearoyl-





Table 1 Altered plasma NEFA, glucose and hormones between WT and BCO2 -/- mice 
Parameters 
WT BCO2-/-  P-value 
Fasting blood glucose (mg/dL) 95.4 ± 16.2 135.3 ± 10.5 0.001 
NEFA (mEq/L) 0.7 ± 0.1 0.96 ± 0.03 0.012 
LDL (mg/dL) 6.6 ± 0.9 10.3 ±0.6 0.001 
Cholesterol (mg/dL) 156.6 ± 18.5 109.5 ±4.0 0.002 
HDL (mg/dL) 93 ± 8.4 55.5 ±3.1 0.000 
Leptin (pg/mL) 2076.5 ± 225.0 537.8 ± 218.3 0.000 
Glucagon (pg/mL) 63.4 ± 24.5 31.5 ± 2.1 0.041 
Insulin (pg/ml) 29.3 ± 11.2 21 ±1.2 0.180 







Fig. 2 Classification of metabolites detected in hypothalamus. Total number of metabolites 












































Amio acid metabolism α-hydroxyisocaproate 10.8234 2.24  * 
methionine 20.6643 0.78 *** 5-hydroxyindoleacetate 10.7699 0.62 ** 
indolelactate 20.173 0.23 *** prolylvaline 10.4117 0.75 ** 
α-hydroxyisovalerate 20.1712 5.6 ***       
tyrosine 19.9737 0.63 * Lipidmetabolism 
pipecolate 19.9522 1.83 *** cholate 19.678 0.03 *** 
urea 19.7835 1.42 *** deoxycholate 19.5741 0.06 ** 
kynurenine 19.7163 0.42 *** taurocholate 19.1587 0.09 ** 
isobutyrylcarnitine 19.5006 0.54 ** stearoylcarnitine 18.7763 0.7 ** 
γ-glutamyltryptophan 19.4767 0.34 *** oleoylcarnitine 18.3828 0.72 ** 
tryptophan 18.9214 0.59 *** N-palmitoyltaurine 18.2983 2.04 * 
prolylalanine 18.8363 0.86 ** tauro-β-muricholate 15.6101 0.19 * 
histidine 18.7456 0.69 ** N-oleoyltaurine 14.4865 1.59 *** 
glycylvaline 18.6505 0.65 ** 1-palmitoylglycerophosphoserine 14.3495 3.5 ** 
allo-threonine 18.6337 2.47 * 1-stearoylglycerophosphoserine 12.6341 1.43 * 
3-(4-hydroxyphenyl)lactate 18.578 0.38 * N-stearoyltaurine 12.0064 1.82 ** 
phenylalanine 18.5146 0.7 * oleate (18:1 n9) 11.7209 0.81 * 
3-indoxyl sulfate 18.5091 0.17 *** 
stearoyl-arachidonoyl-
glycerophosphoinositol 
11.4019 0.71 * 
N-acetyltyrosine 18.4288 0.42 * 
stearoyl-oleoyl-
glycerophosphoserine 
11.1279 2.12 * 
3-methylglutarylcarnitine 18.3195 1.81 **       
γ-glutamylglutamine 17.928 0.65 * Carbohydrate metabolism 
ophthalmate 17.7367 1.67 *** sucrose 20.1652 26.84 ** 
prolylglutamine 17.7356 0.34 * 1,5-anhydroglucitol 18.9579 1.99 *** 
S-methylcysteine 17.5736 0.24 **       
1-methylimidazoleacetate 14.9067 0.54 ** Nucleotide metabolism 
γ-glutamylphenylalanine 14.8001 0.56 * thymidine 19.7096 0.66 ** 
C-glycosyltryptophan 14.7692 1.21 ** adenine 18.3837 0.82 *** 
betaine 14.302 0.69 * 2'-deoxyuridine 13.5304 0.69 ** 
γ-glutamyltyrosine 14.0757 0.48 **       
alanylalanine 13.6308 1.55 ** Cofactors and Vitamins 
N-acetylglutamine 13.5631 0.41 * pantothenate 19.8491 0.5 *** 
2-hydroxy-3-methylvalerate 13.5603 3.01 * riboflavin (Vitamin B2) 16.0771 0.76 * 
4-hydroxy-nonenal-glutathione 13.4777 1.36 ** pyridoxal 11.3895 0.8 * 
N-acetylphenylalanine 13.4647 0.28 *       
leucylglycine 13.0612 0.7 * Xenobiotics 
N-acetyltaurine 12.7174 1.73 ** ergothioneine 19.0424 0.52 * 
glutamine 11.9453 0.68 ** hippurate 18.2248 1.83 ** 
taurine 11.6979 1.32 ** methyl glucopyranoside  18.0238 1.56 *** 
glycylleucine 10.845 0.83 * catechol sulfate 11.7362 0.63 * 
* indicate p-value<0.05; ** indicate p-value<0.01; *** indicate p-value<0.001. 





 LCFAs, such as oleate (18:1 n9) (Fig. 3A), and docosahexaenoate (DHA; 22:6n3) (Fig. 
3B), were significantly lower in BCO2-/- mice. Long-chain acyl-carnitines and N-acyl-taurines in 
hypothalamus changed in reciprocal fashion. Long-chain acyl-carnitines, such as 
palmitoylcarnitine (Fig. 3C), stearoylcarnitine (Fig. 3D), and oleoylcarnitine (Fig. 3E) were 
significantly decreased in BCO2-/- hypothalamus with respect to WT, whereas N-acyl-taurines 
such as, N -palmitoyltaurine (Fig. 3F), N-stearoyltaurine (Fig. 3G), and N-oleoyltaurine (Fig. 
3H) were elevated. Acyl-carnitine conjugation by carnitine palmitoyltransferase (CPT) is 
required for import of LCFA into the mitochondria before fatty acid oxidation. Lower long-chain 
acyl-carnitines level in the hypothalamus indicated decreased transport of LCFAs into the 
mitochondria. 
To determine whether or not BCO2-/- impacts fatty acid synthesis, the expression level of 
acetyl-CoA carboxylase (ACC), which catalyze the rate-limiting step of fatty acid biosynthesis 
was tested in WT and BCO2-/- mice. Result showed that ACC level tended to be higher in BCO2-/- 







Fig. 3 The impact of BCO2 on lipids metabolism. Effect of BCO2 on  (A) oleate, (B) 
docosahexaenoate, (C) palmitoylcarnitine, (D) stearoylcarnitine, (E) oleoylcarnitine, (F) N-
palmitoyltaurine, (G) N-stearoyltaurine, (H) N-oleoyltaurine in the hypothalamus of BCO2-/- 
mice compared to WT mice. The tops and bottoms of the boxes represent the interquartile range, 
the ”+” represents mean value, the solid line in the middle represents the median, and the bars 
(whiskers) representing the range of the data points, the “ο” represents extreme data point, n = 
6.  (I) The expression level of ACC and (J) quantification of ACC between BCO2-/- mice and WT 
mice. n = 2. ACC, acetyl-CoA carboxylase WT, wild type.  *0.01<P<0.05; **0.001<P<0.01; *** 
P<0.001. 





Similar to the decreased LCFA level in hypothalamus of BCO2-/- mice, the glucose level 
was also significantly lower in BCO2-/- mice (Fig. 4A). Contrary to the decreased transport of 
LCFA for β-oxidation, transport of D-glucose and other monosaccharides was activated in the 
BCO2-/- group (Fig. 4B) as predicted by the IPA system. The expression of protein kinase B 
(PKB), also known as AKT, which is a protein kinase that plays a key role in insulin signaling 
pathway and glucose uptake, was not changed (Fig. 4C-D). However, the phosphorylated AKT 
was inhibited in BCO2-/- mice (Fig. 4E). 
3.6. Disrupted sterol metabolism  
Markers associated with sterol metabolism and the conversion of cholesterol to primary 
and secondary bile acids were disrupted in BCO2-/- mice (Fig. 5A). The cholesterol level was 
significantly decreased in BCO2-/- mice (Fig. 5B). This may be due to the elevated 3-hydroxy-3-
methylglutarate (HMG) activity (Fig. 5C). Increased HMG suggests the rate-limiting step of 
cholesterol synthesis-the conversion of HMG-CoA to mevalonate-was restricted in knockout 
animals. This led to the alternative disposal of HMG-CoA via the formation of HMG.  
Bile acid biosynthesis was inhibited in BCO2-/- mice. Decreased levels of cholate (Fig. 
5D), and taurine-conjugate tauroursodeoxycholate (Fig. 5E) indicated that the classic bile acid 
synthesis pathway was inhibited in BCO2-/- mice. The decreased hydroxy-3-oxo-4-cholestenoate 
(7-HOCA) (Fig. 5F) reflected the alternative pathway was also inhibited. Furthermore, the 
secondary bile acids deoxycholate was also decreased in BCO2-/- mice (Fig. 5G). Therefore, both 
primary and secondary bile acids and their conjugates were decreased in BCO2-/- mice as 







Fig. 4  The impact of BCO2 on glucose metabolism. (A) Decreased glucose level in 
hypothalamus. The tops and bottoms of the boxes represent the interquartile range, the ”+” 
represents mean value, the solid line in the middle represents the median, and the bars (whiskers) 
representing the range of the data points, the “ο” represents extreme data point, n = 6. (B) 
Increased  transport of monosaccharides in BCO2-/- mice predicted by Ingenuity Pathway 
Analysis. (C) The change of AKT expression and (D-E) quantification of AKT between BCO2-/- 







Fig. 5 Decreased bile acid metabolism in BCO2 -/- mice compared to WT mice. (A)Classic” 
and “Alternative” pathway of bile acid synthesis. The change of cholesterol (B), 3-hydroxy-3-
methylglutarate (HMG)  (C), cholate (D), tauroursodeoxycholate (E), 7α-hydroxy-3-oxo-4-
cholestenoic acid (7-HOCA) (F), and deoxycholate (G)  in hypothalamus of BCO2-/- mice 
compared to WT mice. The tops and bottoms of the boxes represent the interquartile range, 
the ”+” represents mean value, the solid line in the middle represents the median, and the bars 
(whiskers) representing the range of the data points, the “ο” represents extreme data point, n = 6. 
FXR, farnesoid X receptor; 7-HOCA, 7-α-hydroxy-3-oxo-4-cholestenoate. WT, wild 





3.7. Elevated oxidative stress and inflammation in BCO2-/- mice 
The metabolism of sulfur-containing amino acids is important for one carbon transfer 
catalyzed by methyltransferases as well as for converting methionine into antioxidants such as 
cysteine and glutathione sulfhydryl-containing derivatives (Fig. 6A). The results from global 
metabolon revealed methionine and glutathione transsulfuration was inhibited in BCO2-/- mice. A 
significant decrease in sulfur-containing amino acids such as methionine, S-
adenosylmethionine(SAM), cystathionine and cysteine was observed in BCO2-/- mice compared 
to wild-type mice (Fig. 6B). The elevated level of ophthalmate (OPH), combined with the 
decreased cystathionine and cysteine level in BCO2-/- mice, indicated that cystathionine may 
predominantly convert to α-ketobutyrate and finally form ophthalmate rather than convert to 
cysteine. Significantly increased 4-hydroxy-nonenal-glutathione (4-HNE-GS) and increased trend 
of erythronate (P=0.075), both of which are oxidative stress biomarkers, were also observed in 
BCO2-/- mice. 
Markers of histamine metabolism 1-methylimidazoleacetate was lower in hypothalamus, 
which suggests the basophils - major producers of histamine - may have been relatively less 
active in the hypothalamus of BCO2-/- mice. Decreased histidine (Fig. 6B) and oleate (Fig. 8A), 
which exhibit anti-inflammatory effects, were observed in BCO2-/- mice. 
The glycerophosphoinositol- and glycerophosphoserine- containing fatty acyl groups also 
changed between WT and BCO2-/- mice. The glycerophosphoinositols play a role in 
inflammatory and immune responses and function as modulators of T-cell signaling and T-cell 
responses [153]. Glycerophosphoserines are also involved in cell signaling, especially during 







Fig. 6 Elevated oxidative stress and inflammation in hypothalamus. (A) 
Methionine/Glutathione transsulfuration pathway; (B)The change of metabolites and the pathway 
related to sulfur-containing amino acids and lysolipids. Heat map depicting significant change in 
sulfur-containing amino acids and lysolipids after the deletion of BCO2, as analyzed by LC-








4.1. Altered hormone and nutrients sensing in hypothalamus contribute to feeding behavior 
change in BCO2-/- mice 
Our previous data showed BCO2-/- mice always exhibit higher food intake compared to 
age matched mice. The significant lower circulating leptin levels observed in BCO2-/- mice 
functions as a contributory factor in enhanced appetite. Leptin is an anorectic hormone that binds 
to the leptin receptor (LepR) in hypothalamus to initiate downstream signaling through the 
phosphorylation of transcription factor signal transducer and activators of transcription (STAT) 
and tyrosine kinase Janus kinase (JNK) [155]. In the STAT family, STAT3 is mostly involved in 
leptin-mediated anorectic effects [156]. Phosphorylation of STAT3 participates in the leptin-
induced transcriptional regulation of appetite regulation neuropeptides, such as POMC, AgRP, 
and NPY.  
In addition to lower circulating leptin in BCO2-/- mice, hypothalamic nutrient sensing is 
also involved in regulatingfeeding behavior. The metabolic-sensing neurons in hypothalamus 
regulate peripheral fuel availability by altering behavior in response to glucose and fatty acids 
levels [157]. BCO2-/- mice exhibited significant lower glucose in hypothalamus. Glucose sensing 
is especially important in stimulating appetite when glucose availability drops. Hypothalamic 
glucose level modulates ingestive behavior by  regulating GLUT2, glucokinase, and KATP 
channels [63]. Lower glucose in hypothalamus may reflect an energy deficiency status in BCO2-/- 
mice, thus the BCO2-/- mice exhibit orexigenic phenotype. 
Oleate was significantly decreased in BCO2-/- mice. Approximately 50% of metabolic-
sensing neurons responded to oleic acid by using the FA translocator/receptor FAT/CD36 (CD36) 
[158]. Oleic acid may acutely enhance hepatic insulin action via the activation of KATP channels 





signal in turn activates a series of neuronal events to promote a switch in fuel sources from 
carbohydrates to lipids [74]. Therefore, the decreased oleate level also indicated the tendency 
toward using carbohydrates as fuel in BCO2-/- mice. 
The endocannabinoids, including N-oleoyltaurine, N-stearoyltaurine, and N-
palmitoyltaurine, were significantly elevated in BCO2-/- mice. N-acyl taurines are relatively 
poorly understood members of the endocannabinoid family that are abundant in the brain, 
especially in CNS [159]. These N-acyl taurines may be synthesized from dietary n-3 and n-6 
poly- unsaturated fatty acids by taurine-conjugating enzymes in the hypothalamus, or synthesized 
by acyl-coenzyme A:amino acid N-acyltransferase (ACNAT1) from peripheral tissue and 
transported to the CNS, or both [160]. The endocannabinoid system has emerged as a lipid 
signaling system in macronutrient metabolism in which the gastrointestinal system, liver, muscle, 
and adipose are all involved [161]. The endocannabinoids act as neurotransmitters between 
neurons in various regions of the brain, which may affect neuroendocrine functioning [162]. One 
physiological effect of the endocannabinoid system is to shift the energy balance toward energy 
storage and favor fat accumulation [163]. Increased endocannabinoids and activated cannabinoid 
receptors in the brain lead to increased appetite and obesity [161]. Furthermore, the N-taurine-
conjugated fatty acids have been shown to activate transient receptor potential vanilloid 1 
(TRPV1), and further trigger the release of free calcium ions to the cytosol, which stimulates 
insulin secretion from pancreatic β-cells [164]. 
4.2. Perturbed energy metabolism in BCO2-/- mice 
Traditionally, only glucose was believed to cross the blood-brain barrier to provide ATP 
for the brain. Later, it was discovered that fatty acids are used by brain as well [165]. It has been 
reported that 20% of total energy expenses of the brain are satisfied by oxidation of fatty acids 





(CoA) before they get into mitochondria for β-oxidation. The carnitine palmitoyltransferase 1 
(CPTI) on the outer mitochondrial membrane exchanges carnitine for the CoA group on LCFA to 
form a fatty acid-carnitine conjugate. Uptake of fatty acids into mitochondria is considered as the 
rate-limiting step of β-oxidation. The decrease of long-chain acyl-carnitines (palmitoylcarnitine, 
stearoylcarnitine, and oleoylcarnitine) in this case is consistent with decreased transport of LCFA 
into mitochondria. 
The transport of monosaccharides also changed in BCO2-/- mice. The IPA software 
predicted the activation of the transport of D-glucose and other monosaccharides based on the 
increased sorbitol level; as well as decreased oleic acid, ascorbic acid, tyrosine, methionine, 
cysteine, histidine, tryptophan, threonine, lysine, and phenylalanine level. Sorbitol was reported 
to increase the transport of 2-deoxyglucose in C2C12 cells [167]. The administration of oleic acid 
in the intracerebroventricular of brain markedly inhibits endogenous glucose production. 
Ascorbic acid decreases transport of deoxyglucose in primary cultures of cortical and 
hippocampal neurons and in HEK293 cells [168]. Lysine, histidine, cysteine, tyrosine, 
tryptophan, threonine, phenylalanine, and methionine infusion are found to decrease the transport 
of D-glucose via inhibiting insulin receptor substrate-1 phosphorylation and decreasing insulin-
induced phosphoinositide 3-kinase activity [169]. Therefore, the metabolites discussed above 
indicated that the transport of D-glucose and other monosaccharides might be upregulated due to 
the ablation of BCO2. In addition, the inhibition of AKT in BCO2-/- mice indicated inhibition of 
glucose uptake. AKT may activate glycogen synthesis through phosphorylation and inactivation 
of glycogen synthase kinase 3 (GSK-3) [170]. Overall, the results discussed above reveal that the 
depletion of BCO2 causes down regulation of LCFA oxidation, and leads to the tendency toward 
using glucose as substrate. 





Decreased intermediate products of bile acid synthesis indicated lower bile acid 
biosynthesis in BCO2-/- mice. Although the majority of bile acids are produced by liver, they can 
also be synthesized extrahepatically. Bile acid can either be synthesized or delivered to the brain 
[171, 172]. The pathway initiated by ER localized enzyme cholesterol 7α-hydroxylase (CYP7A1) 
is referred to as the classic (neutral) pathway of bile acid synthesis. The alternative (acidic) 
pathway of bile acid synthesis refers to the process that starts with the hydroxylation of 
cholesterol at the 27 position by the mitochondrial enzyme sterol 27-hydroxylase (CYP27A1). 
For rodents, the acidic pathway can account for up to 25% of total bile acid synthesis [173]. Bile 
acids are synthesized extrahepatically via the acidic pathway starting with 27-hydroxycholesterol, 
or with 24S-hydroxycholesterol pathway [171, 174]. Both the initial steps of these two pathways 
occur in the brain [174]. Moreover, all enzymes needed for the biosynthesis of the primary bile 
acid by the 24S-hydroxycholesterol pathway are found to be expressed in the brain [171].  
The sterols and bile acids may activate and act as ligands to many nuclear receptors in the 
brain, such as liver X receptors (LXRs) and Nur-related factor 1 (NURR1) [171]. The farnesoid X 
receptor (FXR) could also activated by bile acids, such as deoxycholic acid [175]. Therefore, the 
down-regulated bile acid synthesis and decreased cholate, tauroursodeoxycholate, 7-HOCA, and 
deoxycholate indicated less activation of these nuclear receptors.  
The tauroursodeoxycholate in the brain was found to exhibit a protective role against 
motor and cognitive deficits and to reduce striatal degeneration during the development of 
Huntington's disease [172]. It has been reported that hydrophilic bile acids may exhibit 
antioxidant properties and interact with the mitochondrial membrane to prevent mitochondrial 
permeability transition (MPT), mitochondrial membrane depolarization, and cytochrome c release 
[172, 176]. Thus, the decreased bile acids level in BCO2-/- mice also indicates the risk of neuron 





4.4. Ablation of BCO2 leads to oxidative stress 
Global metabolon data indicated decreased methionine, SAM, cystathionine and cysteine 
levels, as well as increased 4-HNE-GS and ophthalmate level. Methionine plays an important role 
against peroxidation of lipids, a process in which free radicals steal electrons from lipids in cell 
membranes, causing cell damage [177]. SAM is the major methyl donor in the body, and a 
provider of cysteine for synthesis of GSH. It may also function as a direct antioxidant in the cell 
[178]. Our results indicated reduced antioxidant activity in the hypothalamus after the knockout 
of BCO2. OPH is synthesized when GSH is depleted and when the hepatic availability of cysteine 
is limited. Although glutathione levels did not differ between hypothalamic samples taken from 
WT and BCO2-/- animals, the OPH, which is a marker of glutathione depletion, was significantly 
elevated in the BCO2-/- samples.  
Increased 4-HNE-GS, a peroxidative stress biomarker, indicated that peroxidative stress 
was greater when BCO2 expression was suppressed and that glutathione was needed to neutralize 
these reactive compounds. Another elevated oxidative damage biomarker-erythronate, which is 
the oxidation product of N-acetylglucosamine, indicated that the loss of BCO2 expression in the 
hypothalamus led to an increased level of oxidative stress and damage [179].  Furthermore, HMG 
was reported to induce protein oxidative damage in cortical supernatants and to reduce 
nonenzymatic antioxidant potential and total antioxidant capacity in rat cerebral cortex [180]. 
Significantly higher HMG level also indicated elevated oxidative stress in BCO2-/- mice. 
4.5. Increased risk of diabetes  
AKT is an important signaling molecule in the insulin signaling pathway, which 
functions as an effector of the PI3K [181]. The major effect of AKT in glucose metabolism is the 
stimulation of glucose uptake in skeletal muscle, liver, adipocytes and other tissues by 





glycogen synthesis [182]. Inhibition of AKT in BCO2-/- mice indicate decreased glucose uptake 
in peripheral tissues. The inhibited AKT may be associated with impaired insulin signaling 
pathways. 
Significantly decreased glutamine, kynurenine, and tryptophan, and increased taurine 
were also associated with a high risk for developing diabetes in BCO2-/- mice. Metabolome 
analysis of spontaneously diabetic Torii (SDT) rat models identified significantly altered 
metabolites including glutamine, kynurenine, tryptophan, and taurine, which are all potential 
biomarkers for prediabetes [183].  Decreased tryptophan levels were observed in the 
hypothalamus [184] and other brain regions [185] in diabetic rats. L-glutamine was also found to 
promote insulin response, trigger GLP-1 release, and decrease postprandial glycaemia in type 2 
diabetes patients [186].  A novel genetic locus located in the region of the  GLUL gene on 
chromosome 1q25 was found to be associated with higher coronary heart disease risk among type 
2 diabetic patients as a result of reduced GLUL gene expression [187].  
4.6. Impaired brain and neuron function 
Decreased betaine, 5-methylthioadenosine (MTA), and DHA are associated with 
impaired brain and neuron function. Betaine may delay the progression of Alzheimer's disease 
due to a decrease in serum homocysteine, and an increase of brain methionone and SAM [188]. 
Betaine also protects against rotenone-induced neurotoxicity in PC12 cells [189]. MTA displays a 
wide array of neuroprotective activities against different insults [190]. DHA is an omega-3 fatty 
acid, which is a critical structural component of the brain and important for central nervous 
system function [191]. DHA exhibits neuroprotective function, increases cerebral acetylcholine 
levels and enhances learning ability in rats [192]. It exihibits anti-inflammation role by inhibiting 





ventromedial hypothalamus, which leads to the defects in insulin action, is a possible factor in the 
development of Type 2 diabetes [193].  
4.7. BCO2 may be important for cellular metabolism and feeding behavior, rather than 
simply functioning as a carotenoids cleavage enzyme 
It has been reported that carotenoids were found to accumulate in the mitochondria of 
BCO2-/- mice when mice were fed zeaxanthin or lutein diets [23]. The accumulated carotenoids 
led to mitochondrial dysfunction, as indicated by the increased MnSOD level and decreased 
respiratory activity [23]. However, in our study, no carotenoid was added into the diet. Therefore, 
BCO2 may maintain mitochondrial function not only through the homeostasis of carotenoid 
metabolism, but also through other mechanisms This study demonstrates that BCO2 depletion 
impacts  energy metabolism, nutrient sensing, oxidative stress, and inflammation in mice at the 
level of the hypothalamus. The altered circulating hormone level, glucose and fatty acids sensing 
may contribute to the change of feeding behavior, thus resulting to the BCO2-/- mice exhibiting 








 THE ROLE OF BCO2 IN MAINTAINING HYPOTHALAMIC MITOCHONDRIAL 
PROTEOMICS AND RESPIRATORY ACTIVITY 
 
1. Introduction 
The hypothalamus is a key brain region for modulating feeding behavior and energy 
expenditure through nutrient sensing [8, 9] and signal integration from central and peripheral 
pathways [10]. The proopiomelanocortin (POMC) and agouti-related protein (AgRP)/neuropeptide 
Y (NPY) neurons response to leptin, insulin, and gut hormones, such as ghrelin, glucagon-like 
peptide-1, peptide YY3–36, cholecystokinin,  and pancreatic polypeptide to maintain energy 
balance [10, 11]. Aside from the signals from hormones, the hypothalamus is also sensitive to 
circulating metabolites. Circulating lipids such as oleic acid provides a signal of “nutrient 
abundance” in the CNS. This signal in turn activates a series of neuronal events to promote a switch 
in fuel sources from carbohydrates to lipids [74]. Glucosensing neurons sense ambient glucose by 
regulating membrane potential, firing rates, and ion channels [60]. Glucose sensing is especially 
important in stimulating appetite when glucose availability drops [63]. 
 Hypothalamic mitochondrial dynamics is also involved in the modulation of whole energy 
homeostasis [12, 13]. Mitochondria regulate AGRP and POMC neuronal activity through fission 
and fusion behavior and morphology changes in response to the environment especially to the 





impaired mitochondrial ATP production. Research has shown that altered mitochondrial energy 
production, especially in skeletal muscles, is a major factor that disrups a chain of metabolic events 
leading to obesity [14]. Besides its function in energy production, mitochondria participate in many 
other processes including cell signalling, cell differentiation, and apoptosis [87]. Mitochondria are 
also involved in the generation of reactive oxygen species (ROS), endoplasmic reticulum (ER) 
stress, and inflammation [194, 195]. Mitochondrial dysfunction is thought to trigger many chronic 
diseases, including obesity, diabetes, and neurodegenerative diseases, such as Parkinson’s disease 
and Alzheimer’s disease [97]. 
 Recently, BCO2 (β,β-carotene-9’,10’-oxygenase2) was reported to play an important role 
in protecting mitochondrial function [23]. BCO2 is an enzyme in the mitochondria that catalyzes 
asymmetric cleavage of both provitamin and non-provitamin A carotenoids at 9’, 10’ double bond 
to form β-ionone and β-apo-10’-carotenal [15]. BCO2 was found to be in the inner mitochondrial 
membrane, where complexes of the electron transport chain (ETC)/oxidative phosphorylation 
(OXPHOS) are located [31]. The deletion of BCO2 led to the disrupted carotenoid homeostasis 
accompanied by elevated oxidative and reduced respiratory activity when mice were fed with 
carotenoids [23].  
However, our earlier finding showed BCO2-/- mice are more prone to obesity and exhibit 
higher food intake compare to wide type (WT) mice, even when they are fed with chow diet without 
or with trace amount of carotenoids. This leads to the hypothesis that BCO2 might play a crucial 
role to protect mitochondrial function other than just enzymatic function. The aim of this study is 
to explore the mechanism of how BCO2 maintains mitochondrial function by determining the 
impact of BCO2 on mitochondrial proteomics and respiratory activity. 
 





2.1. Animals and animal Care  
Male 129S6 WT and BCO2-/- mice at six weeks of age were selected and group-housed 
(3 mice/cage) in a controlled environment with a 12-h/12-h light/dark cycle. Mice were fed a 
regular chow diet (CD, 13.4% kcal from fat, #5001; LabDiet, St Louis, MO). All mice had free 
access to water and food throughout the study. Hypothalamic tissues were collected for laboratory 
analyses. The animal protocol was approved by the Institutional Animal Care and Use Committee 
(IACUC) of Oklahoma State University.  
2.2. Mitochondria isolation 
Hypothalamus (60 mg) was homogenized (Qiagen tissuerupter) in 0.5 mL mitochondrial 
isolation buffer (210 mM mannitol, 70 mM sucrose, 5 Mm 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES)), 1 mM ethylene glycol tetraacetic acid (EGTA) and 
0.5% (w/v) fatty acid-free BSA, pH 7.2). The homogenate was centrifuged (600g, 5 minutes, 4 
°C), and the supernatant was collected for further centrifugation (5000g, 5 min, 4 °C).  The pellet 
was re-suspended in 1 mL mitochondrial isolation buffer and centrifuged again for 5 minutes 
(5000g, 4 °C). After removing the supernatant, the remaining mitochondrial pellet was re-
suspended in 1 mL mitochondrial assay solution (1x MAS:  70 mM sucrose, 220 mM mannitol, 
10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% (w/v) fatty acid-free BSA). 
Total protein (ug/mL) was determined by the bicinchoninic acid assay kit (BCA assay, Pierce, 
Rockford, IL). 
2.3. Mitochondrial proteome  
Purified mitochondria (24 μg) were subjected to LC-MS/MS in Proteomics Core Facility 
of Oklahoma State University. Each genotype had 3 biological replicates, and 4 technical 
replicates. Spectral counting was applied for quantifying relative changes in protein abundance. 





fold change of protein expression level. 
2.4 Ingenuity pathway analysis (IPA)  
The metabolites identified in global metabolomic profiling with their p-value and fold 
change were uploaded to the IPA-Metabolomics platform. This platform is capable of integrating 
proteomics and transcriptomics data to identify significantly perturbed pathways, metabolic 
regulators, and novel biomarkers.  
2.5. “Coupling assay” and “Electron flow” respiration analysis  
Isolated hypothalamic mitochondria were used for “coupling assay” and “electron flow” 
respiration assay using the Seahorse XF96 Flux Analyzer (Seahorse Bioscience Inc., MA). All 
steps were conducted on ice unless otherwise stated. 4ug of mitochondria were loaded into each 
well of a XFe 96 cell culture microplate (Seahorse Bioscience Inc., MA). After centrifuging the 
microplate (2000 rpm, 10min, 4 °C), 70 uL pre-warmed (37 °C) 1x MAS,  90 uL pre- warmed 
(37 °C) coupling assay substrate (2x MAS with 10 mM pyruvate, 10 mM malate, and 10 mM 
succinate, pH=7.2) or electron flow substrate (2x MAS with 10 mM pyruvate, 10 mM malate, and 
4 uM FCCP, pH=7.2) was gently added into each well. The plate was loaded into Extracellular 
Flux XFe 96 Analyzer (Seahorse Bioscience Inc., MA) to initiate the assay. ADP (4 mM, final), 
oligomycin (1.5 uM, final), FCCP (4 uM, final), and antimycin A (4 uM, final) were injected 
subsequently for coupling assay. For electron flow assay, rotenone (2 uM, final), succinate (10 
mM, final), antimycin A (4 uM, final), and ascorbate /TMP [(10 mM) /(100 uM), final] were 
injected into each well. The oxygen consumption rate (OCR) during the whole process was 
measured. 
2.6. Statistical analyses 
Data were presented as mean ± SD. The results from respiration assay were processed by 





(pMoles/min/well) vs. time. The differences in protein expression level and respiratory activity 
between WT and BCO2-/- mice were analyzed using student’s t-test. Statistical significance was 
set at p < 0.05.  
 
3. Results  
3.1. Altered hypothalamic mitochondrial proteomics in BCO2-/- mice 
One hundred forty five mitochondrial proteins were identified by LC-MS/MS. To identify 
the difference in hypothalamic protein expression between WT and BCO2-/- mice, the cutoff point 
ratio (BCO2-/-/WT) was set at ratio < 0.85 or ratio > 1.15, with p-value < 0.05 determined by two-
tailed student’s t-test. Among the 145 identified proteins, 30 hypothalamic mitochondrial proteins 
expressed differently in BCO2-/- mice compared to WT mice. Twenty-five of the proteins were 
down-regulated, while only five of them were up-regulated in BCO2-/- hypothalamus. The 
functional categorization of proteins differently expressed between genotypes was summarized in 
Table 1. Most of the proteins related to ETC, Krebs cycle, protein metabolism, and mitochondrial 






Table 3 Functional categorization of proteins differently expressed in hypothalamic mitochondria 
of BCO2-/-  mice vs. wild type (WT) mice 







NDUFA6 NADH dehydrogenase 1 α subcomplex subunit 6 0.2692 0.0294 
CYC1 Cytochrome c1, heme protein 0.5033 0.0169 
NDUFS6 NADH dehydrogenase  iron-sulfur protein 6 0.5414 0.0536 
CISD1 CDGSH iron-sulfur domain 1   0.5856 0.003 
ATP5C1 ATP synthase subunit γ 0.7023 0.0016 
ATP5F1 ATP synthase F(0) complex subunit B1 0.6325 0.039 
NDUFA9 NADH dehydrogenase 1α subcomplex subunit 9 0.655 0.0326 
NDUFS7 NADH dehydrogenase iron-sulfur protein 7 0.7549 0.042 
SDHA Succinate dehydrogenase flavoprotein subunit 0.7639 0.046 
NDUFA11 NADH dehydrogenase 1α subcomplex subunit 11 10.125 0.0303 
TCA 
IDH3A Isocitrate dehydrogenase NAD subunit  α 0.6222 0.0264 
PC Pyruvate carboxylase  0.6532 0.0021 
PDHA1 Pyruvate dehydrogenase E1 component subunit α, somatic form 0.7948 0.0023 
MDH2 Malate dehydrogenase 2 0.8213 0.0451 
β-oxidation 
HADHB Mitochondrial trifunctional protein subunit β 0.8202 0.0125 
LACS6 Long chain acyl-CoA synthetase 6 isoform 3 1.322 0.0406 
Protein metabolism,  folding, degradation 
HYOU1 Hypoxia up-regulated protein 1 protein  0.0465 0.0501 
IVD Isovaleryl-CoA dehydrogenase  0.2458 0.0377 
MAOA Amine oxidases (AO) flavin-containing  0.5055 0.0033 
GOT2 Glutamic-Oxaloacetic Transaminase 2 0.828 0.0236 
Membrane protein 
CKMT1 Creatine kinase 1 0.6126 0.0056 
VDAC3 Voltage-dependent anion channel 3 0.6716 0.0027 
VDAC1 Voltage dependent anion channel 1  0.7019 0.0158 
SLC25A4 solute carrier family 25, member 4 0.707 0.0489 
TOMM70A Mitochondrial import receptor subunit TOM70  0.7562 0.0127 
SLC25A5 solute carrier family 25, member 5 0.7739 0.0348 
Misc 
CTNNB1 Catenin β-1 0.7007 0.0258 
TPI1 Triosephosphate isomerase   1.6212 0.0179 
PGK1 Phosphoglycerate kinase 1 3.65 0.015 








3.2. Canonical pathway analysis between WT and BCO2-/- mice 
To further investigate the impact of BCO2 on hypothalamic mitochondrial metabolism and 
function, the canonical pathway analysis was performed (Fig 7). The top 12 altered pathways 
ranked by the p-value were mitochondrial dysfunction, oxidative phosphorylation, EIF2 signaling, 
fatty acid β-oxidation, valine degradation, phagosome maturation, TCA Cycle II (Eukaryotic), 
remodeling of epithelial adherens junctions, clathrin-mediated endocytosis signaling, GABA 
receptor signaling, isoleucine degradation, and Huntington’s disease signaling. All 12 pathways 
were down-regulated in BCO2-/- mice hypothalamus compared to WT group.  
3.3. Perturbed energy utilization caused by the deletion of BCO2  
The impact of BCO2 on mitochondrial energy utilization pathway is shown in Fig 8. The 
Krebs cycle is the central metabolic pathway in aerobic organisms that generates a pool of chemical 
energy in the form of ATP, NADH, and FADH2. Five enzymes involved in Krebs cycle, including 
pyruvate carboxylase (PC), pyruvate dehydrogenase E1 component subunit α (PDHA1), succinate 
dehydrogenase flavoprotein subunit (SDHA), malate dehydrogenase (MDH2), and isocitrate 
dehydrogenase NAD subunit α (IDH3AI) were inhibited. The decreased PC and PDHA1 led to the 
inhibition of pyruvate converting to both oxaloacetate and acetyl-CoA, which may result in the 
overall down-regulation of Krebs cycle as indicated by canonical pathway analysis (Fig 7).  
Fatty acid β-oxidation was also affected by BCO2. LCFA need to be activated by fatty acyl 
CoA synthetase to form long chain fatty acyl CoA before β-oxidation. The expression level of long 
chain acyl-CoA synthetase 6 isoform 3 (LACS6) was increased in BCO2-/- mice compared to WT 
mice. However, the expression of mitochondrial trifunctional protein subunit β (HADHB), which 
catalyzes the last three steps of mitochondrial β-oxidation of LCFAs was decreased in the 








Fig. 7 The change in canonical pathways between WT and BCO2
-/-
 mice. The list of proteins 
identified from LC-MS/MS was analyzed by ingenuity pathway analysis (IPA) platform. The top 







Fig. 8 Altered energy utilization caused by the deletion of BCO2. The proteins were identified 
from LC-MS/MS. Proteins expressed differently between genotypes related to Krebs cycle and 
fatty acid β-oxidation are shown in the figure. The cutoff point of ratio (BCO2
-/-
 /WT) change 
was set at ratio < 0.85 or ratio > 1.15, with p-value < 0.05 determined by two-tailed student’s t-
test. PC: Pyruvate carboxylase; PDHA1:Pyruvate dehydrogenase E1 component subunit α; 
MDH2:Malate dehydrogenase; SDHA: Succinate dehydrogenase flavoprotein subunit; 
IDH3AI:socitrate dehydrogenase NAD subunit α; HADHB: Mitochondrial trifunctional protein 







3.4. Impact of BCO2 on ETC 
The NADH and FADH2 generated during the Krebs cycle and LCFAs β-oxidation are 
oxidized through ETC/OXPHOS to produce large amount of ATP. Except for complex III, all the 
other complexes were affected by the deletion of BCO2 (Fig. 9). For complex I, the expression of 
NADH dehydrogenase 1 α subcomplex subunit 6 (NDUFA6) and subunit 9 (NDUFA9), as well as 
NADH dehydrogenase iron-sulfur protein 6 (NDUFS6) and 7 (NDUFS7) were decreased; while 
NADH dehydrogenase 1 α subcomplex subunit 11(NDUFA11) was increased. The SDHA in 
complex II was down-regulated. ATP synthase subunit γ (ATP5C1) and ATP synthase F(0) complex 
subunit B1 (ATP5F1) were down-regulated in BCO2-/- mice as well.  
Besides the impacts on complexes of ETC, BCO2 knockout also led to the decreased 
expression of cytochrome C1 (CYC1), which plays an important role in transporting the electron 
from complex III to complex IV. In addition, the CDGSH Iron Sulfur Domain 1(CISD1) is the 
protein that plays a key role in regulating maximal capacity for electron transport and oxidative 
phosphorylation, it binds to the redox-active Fe-S cluster. Decreased CISD1 here indicated lower 
efficiency in KO mice.Furthermore, decreased expression of mitochondrial antioxidant MnSOD, 
which functions to detoxify superoxide into hydrogen peroxide and diatomic oxygen, was also 
observed in BCO2-/- mice (p = 0.058).  
3.5. The impact of BCO2 on hypothalamic mitochondrial respiratory capacity  
Functional analyses of isolated hypothalamic mitochondria were conducted to study the 
effect of BCO2 on hypothalamic mitochondrial respiratory capacity (Fig 4). The result from 
coupling assay showed that mitochondrial basal respiration rate, maximal respiration rate, and 
proton leak did not significantly change between WT and BCO2-/- mice. For the capacity of each 
ETC complex, the capacity of complex II was significantly decreased in BCO2-/- mice, while the 






Fig. 9 The impact of BCO2 on electron transport chain. The proteins were identified from LC-
MS/MS. The cutoff point of Ratio (BCO2
-/-
/ WT) change was set at ratio < 0.85 or ratio > 1.15, 
with p-value < 0.05 (except MnSOD) determined by two-tailed student’s t-test. UQ: ubiquinone; 
Cyto C: Cytochrome C;NDUFA6:NADH dehydrogenase 1 α subcomplex subunit 6; NDUFA9: 
NADH dehydrogenase 1 α subcomplex subunit 9; NDUFS6: NADH dehydrogenase iron-sulfur 
protein 6; NDUFS7: NADH dehydrogenase iron-sulfur protein 7; NDUFA11: NADH 
dehydrogenase1 α subcomplex subunit 11; SDHA: Succinate dehydrogenase flavoprotein 
subunit; CYC1:Cytochrome c1, heme protein; ATP5C1: ATP synthase subunit γ; ATP5F1:ATP 
synthase F(0) complex subunit B1; CISD1: CDGSH Iron Sulfur Domain 1; MnSOD: 









Fig. 10 Mitochondrial respiration rate (A) and capacity of each complex (B) between WT 
and BCO2
-/-
 mice. Oxygen consumption rate was measured using isolated mitochondria from 









In this study, the impacts of BCO2 on mitochondrial proteomics and function in the 
hypothalamus were analyzed. The brain acts as the commander to regulate of energy homeostasis 
by adjusting both eating behavior and energy expenditure in response to many signals including 
nutritional status and circulating hormone levels [196]. Such regulation is a highly complex process, 
involving different brain regions ranging from cortex to brainstem, but the hypothalamus is the 
focus of peripheral signals and neural pathways that modulate energy homeostasis and body weight 
[196, 197]. As the major organelle producing ATP in the hypothalamus, hypothalamic mitochondria 
also affect appetite control and energy balance. Hypothalamic mitochondria dysfunction is found 
to be associated with anorexia in anx/anx mice [198]. It has been reported that BCO2 is important 
in maintaining mitochondrial function by reversing elevated oxidative stress and decreasing 
respiratory activity caused by the accumulation of carotenoids from the diet [23]. However, such 
protective effects were based on the enzymatic function of BCO2. Our earlier research found the 
decreased expression of BCO2 in both obese and diabetic mice even when the mice were fed a 
chow diet without carotenoids [20, 21]. Furthermore, BCO2 was found to be in the inner 
mitochondrial membrane, where complexes of the ETC/OXPHOS are located [31]. The evidence 
discussed above leads us to hypothesize that BCO2 may be important for mitochondrial function 
and overall energy homeostasis, rather than simply functioning as a carotenoid cleavage enzyme.  
The first objective of the study was to illustrate altered mitochondrial proteomics caused 
by the absence of BCO2. Results showed that among the 30 significantly changed proteins, 25 of 
them were down regulated. The major altered pathways include ETC/OXPHOS, Krebs cycle, fatty 
acids β-oxidation, and protein metabolism.  
 





dehydrogenase, NDUFA11, was increased in BCO2-/- mice; however, the other four subunits 
(NDUFA6, NDUFA9, NDUFS6, NDUFS7) were all decreased. Besides the proteins involved in 
complex I, the succinate dehydrogenase (SDHA), and ATP synthase (ATP5C1 and ATP5F1) were 
also down-regulated in BCO2-/- mice compared to WT mice. Moreover, the CYC1, which is an 
electron carrier, was decreased by 49.7% in BCO2-/- mice. The superoxide anion radicals are by-
products of ETC due to the leakage of electron to oxygen molecules in the mitochondrial matrix. 
The mitochondrial antioxidant manganese superoxide dismutase (MnSOD) is an important enzyme 
which detoxifies superoxide anions into hydrogen peroxide. Lower MnSOD levels may associate 
with higher susceptibility to oxidative stress and mitochondrial dysfunction resulting from 
elevation of ROS [199].  
Krebs cycle generates most of the NADH and FADH2 that are used for ETC/OXPHOS. 
Stability of the cellular function of mitochondria requires the integrity of enzymatic reactions. Our 
data showed that BCO2-/- mice might have some problems with the regeneration of oxaloacetate, 
and the formation of acetyl-CoA, as revealed by the decreased PC and PDHA1 in BCO2-/- mice 
leading to less substrate entering the Krebs cycle. Less expressed in BCO2-/- mice were enzymes 
involved in the Krebs cycle, such as MDH2, which converts oxalosuccinate to α-ketoglutarate; 
SDHA that oxidizes succinate into fumarate; and IDH3AI that produces oxaloacetate and NADH 
from malate. 
The canonical pathway analysis also revealed mitochondrial dysfunction in the 
hypothalamus of BCO2-/- mice. The function of the central nervous system is highly dependent on 
efficient mitochondria, due to the high energy demand of brain tissue [195]. Mitochondria are 
highly dynamic organelles that fuse and fission in response to environmental and energy demands. 
Besides the altered energy metabolism pathway, mitochondrial dysfunction also leads to increased 





dysfunction are a major contributor to oxidative damage in the brain [200]. Mitochondria 
dysfunction is reported to play an important role in the ageing process and neurodegenerative 
disease, including Parkinson's disease [201, 202], Alzheimer's disease [203], and Huntington's 
disease [204, 205]. Furthermore, mitochondrial dysfunction and oxidative stress may be associated 
with abnormal brain function and psychiatric disorders, such as depression [206, 207]. 
The second aim of this study was to evaluate the impact of BCO2 on the respiratory activity 
of hypothalamic mitochondria. The absence of BCO2 led to significantly decreased capacity of 
complex II. In complex II, succinate dehydrogenase receives electrons to produce fumarate and 
FADH2, which then passes electrons to ubiquinone for the next steps of electron transport. The 
lower capacity of complex II is consistent with the decreased SDHA level in BCO2-/- mice as shown 
by the proteome data. The basal respiration rate, proton leak and capacity of complex I and IV did 
not change between WT and BCO2-/- mice. Since complex I, complex III, and complex IV are the 
proton pumps to form the proton gradient used for complex V to produce ATP, it is reasonable that 
the proton leak did not change between genotypes.  
In summary, the BCO2 may have additional functions beyond that of carotene cleavage 
enzyme. It is important in maintaining mitochondrial function through the regulation of energy 
utilization, such as Krebs cycle, fatty acid β-oxidation, and ETC. Previously, most studies related 
to BCO2 were focused on the enzymatic function. This is the first research to assess the function 
of BCO2 on hypothalamic mitochondrial proteomics and respiratory activity in addition to its 
enzymatic function. Mitochondrial dysfunction has been considered as a major cause of aging and 
an underlying contributor to many neurodegenerative diseases [201, 203, 205, 208], as well as be 
associated with  diabetes [52, 209], obesity [91], and even cancer [210]. Elucidating changes in 





the role of BCO2 in maintaining hypothalamic function. Building on this innovative approach, 









Previously, most studies conducted on the function of BCO2 were focused on the 
enzymatic function. However, our lab found BCO2-/- mice exhibit higher food intake, and are  
more prone to obesity compare to wide type mice, even when mice were fed with chow diet, 
without carotenoids or just trace mount of carotenoids. The present study aims to demonstrated 
the mechanism how BCO2 impacts mitochondrial function and hypothalamic metabolome, and 
subsequent stimulates feeding behavior. 
By using BCO2-/- mice model, we demonstrated inner mitochondrial membrane protein 
BCO2 does not only function as carotenoids cleavage enzyme. It is important to maintain 
mitochondrial function through the regulation of nutrients metabolism and utilization. The 
deletion of BCO2 lead to mitochondrial dysfunction, and significantly down-regulate of fatty acid 
β-oxidation, TCA Cycle and ETC pathways. BCO2 also protects mitochondria by maintaining 
MnSOD level to detoxify superoxide. For the mitochondrial respiratory activity, BCO2 is crucial 
to maintain the capacity of complex II of ETC.  
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Within the hypothalamus, the deletion of BCO2 leads to significantly lower level of 
glucose and LCFAs, such as oleic acid and DHA, which produce the nutrients depletion signal to 
stimulate appetite. The significantly lower circulating leptin level in BCO2-/- mice is another 
stimulus of appetite. Disrupted glucose and lipid metabolism, and inhibited bile acid metabolism 
leads to the consequent elevated oxidative stress and inflammation, which in turn contribute to 
the orexigenic phenotype. All these factors lead to a higher risk to develop into obesity of BCO2-/- 
mice. 
In conclusion, the results presented here indicate that BCO2 contributes to hypothalamic 
mitochondrial function through its impact on the fatty acid oxidation, TCA cycle, and 
ETC/OXPHOS. The complete ablation of BCO2 could perturb energy metabolism, induce elevate 
oxidative stress, and impair cell signaling in hypothalamus. Current study is also the fundamental 
step of this new perspective. Our study also has some limitations. First, even though 477 
metabolites have been measured by LC-MS/MS, some important metabolites, such as succinate, 
malonyl CoA, and LCFA-CoA cannot be detected due to technical limitation. This limitation 
prevented from being able to draw a more complete picture of how metabolism was altered by 
deletion of the BCO2 gene. Second, although low leptin levels provided us with a reasonable 
explanation for the increased appetite in BCO2-/- mice, we do not know why leptin levels 
decreased so dramatically in the BCO2-/- mice. Our next step in his research will be to focus on 
the impact of BCO2 on leptin production and leptin signaling to establish a better understanding 
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